Stocks / NASDAQ / Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc

Industry:   Health Care - Biotechnology: Biological Products (No Diagnostic Substances) Stock Symbol:   ADAP - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Adaptimmune Therapeutics plc is on the Cruelty Free Investing use of animals list because they use animal testing for their drugs.

Company Description

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR)  and produce TCR therapeutic candidates for administration to patients.

Website: http://www.adaptimmune.com

Contact:   https://www.adaptimmune.com/contact; IR: ir@adaptimmune.com;